Pathophysiological effects of aldosterone in cardiovascular tissues

American Heart Association (1999) 2000 Heart and Stroke Statistical Update, American Heart Association Joint National Committee on Prevention, Detection, Evaluation and Treatment of Blood Pressure (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of Blood Pressure. Arch. Intern. Med. 157, 2413–2446 Brunner, 1972, Essential hypertension: renin and aldosterone, heart attack and stroke, New Engl. J. Med., 286, 441, 10.1056/NEJM197203022860901 Alderman, 1991, Association of the renin–sodium profile with the risk of myocardial infarction in patients with hypertension, New Engl. J. Med., 324, 1098, 10.1056/NEJM199104183241605 The SOLVD Investigators (1992) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl. J. Med. 327, 685–691 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial, New Engl. J. Med., 327, 669, 10.1056/NEJM199209033271001 The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342, 812–828 Pitt, 1997, Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE), Lancet, 349, 747, 10.1016/S0140-6736(97)01187-2 Thürmann, 1998, Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension, Circulation, 98, 2037, 10.1161/01.CIR.98.19.2037 Laragh, 1990, The renin–angiotensin–aldosterone system in hypertensive disorders: a key to two forms of arteriolar constriction and a possible clue to risk of vascular injury (heart attack and stroke) and prognosis, 1329 Ferrario, 1996, Pathologic consequences of increased angiotensin II activity, Cardiovasc. Drugs Ther., 10, 511, 10.1007/BF00050990 Mangelsdorf, 1995, The nuclear receptor superfamily: the second decade, Cell, 83, 835, 10.1016/0092-8674(95)90199-X Pratt, 1993, The role of heat shock proteins in regulating the function, folding and trafficking of the glucocorticoid receptor, J. Biol. Chem., 268, 21455, 10.1016/S0021-9258(20)80556-0 Funder, 1996, 11 Beta-hydroxysteroid dehydrogenase: new answers, new questions, Eur. J. Endocrinol., 134, 267, 10.1530/eje.0.1340267 Bhargava, 2001, The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action, Endocrinology, 142, 1587, 10.1210/en.142.4.1587 Granger, 1999, Role of nitric oxide in modulating renal function and arterial pressure during chronic aldosterone excess, Am. J. Physiol., 276, R197 Lombes, 1995, Prerequisite for cardiac aldosterone action: mineralocorticoid receptor and 11 β-hydroxysteroid dehydrogenase in the human heart, Circulation, 92, 175, 10.1161/01.CIR.92.2.175 Roland, 1995, Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies, Mol. Cell. Endocrinol., 111, R1, 10.1016/0303-7207(95)03559-P Takeda, 1997, Vascular aldosterone in genetically hypertensive rats, Hypertension, 29, 45, 10.1161/01.HYP.29.1.45 Sato, 1996, High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes, Endocrinology, 137, 4145, 10.1210/en.137.10.4145 Mihailidou, 2000, Hyperaldosteronemia in rabbits inhibits the cardiac sarcolemmal Na(+)–K(+) pump, Circ. Res., 86, 37, 10.1161/01.RES.86.1.37 Mihailidou, 2000, Protein kinase C-ε regulates cardiac Na+–K+ pump function in hyperaldosteronemia, Circulation., 102, 135 Moreau, 1996, Effects of aldosterone and spironolactone on the isolated perfused rat heart, Pharmacology, 53, 28, 10.1159/000139412 Benitah, 1999, Aldosterone upregulates Ca2+ current in adult rat cardiomyocytes, Circ. Res., 85, 1139, 10.1161/01.RES.85.12.1139 Gómez-Sánchez, 1990, ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension, Am. J. Physiol., 258, E649 Gómez-Sánchez, 1990, Intracerebroventricular infusion of RU 28318 blocks aldosterone-salt hypertension, Am. J. Physiol., 258, E482 Young, 1995, Determinants of cardiac fibrosis in experimental hypermineralocorticoid states, Am. J. Physiol., 269, E657 Wehling, 1995, Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells, Circ. Res., 76, 973, 10.1161/01.RES.76.6.973 Christ, 1995, Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells, Hypertension, 25, 117, 10.1161/01.HYP.25.1.117 Alzamora, 2000, Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries, Hypertension, 35, 1099, 10.1161/01.HYP.35.5.1099 Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol. Chem., 379, 907 Stier, 1998, Non-epithelial effects of aldosterone, Curr. Opin. Endocrinol. Diabetes, 5, 211, 10.1097/00060793-199806000-00011 Someren, 1999, Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms, Biochem. Biophys. Res. Commun., 260, 619, 10.1006/bbrc.1999.0800 Darrow, 1942, The production of cardiac lesions by repeated injections of deoxycorticosterone acetate, J. Clin. Invest., 21, 601, 10.1172/JCI101338 Robert, 1956, Complete prevention of cerebral accidents in malignant hypertension, Circ. Res., 4, 527, 10.1161/01.RES.4.5.527 Selye, 1943, Malignant hypertension produced by treatment with deoxycorticosterone acetate and sodium chloride, Can. Med. Assoc. J., 49, 88 Hill, 1968, Steroid-induced hypertension in the rat, Am. J. Pathol., 52, 1 Still, 1969, The pathogenesis of glomerular changes in steroid-induced hypertension in the rat, Lab. Invest., 20, 249 Gavras, 1975, Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Role of renin and sodium in vascular changes, Circ. Res., 36, 300, 10.1161/01.RES.36.2.300 Mistry, 1990, Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade, J. Hypertens., 8, 77, 10.1097/00004872-199001000-00012 Stier, 1991, Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect, Am. J. Hypertens., 4, 680, 10.1093/ajh/4.8.680 Stier, 1989, Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats, Hypertension, 13, 115, 10.1161/01.HYP.13.2.115 Rocha, 1998, Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats, Hypertension, 31, 451, 10.1161/01.HYP.31.1.451 Rocha, 1998, Role of mineralocorticoids in renal injury in stroke prone spontaneously hypertensive rats, Hypertension, 32, 598A Rocha, 1998, Adrenalectomy prevents renal vascular injury in stroke prone SHR, J. Am. Soc. Nephrol., 9, A2065 Rocha, 1999, Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats, Hypertension, 33, 232, 10.1161/01.HYP.33.1.232 Greene, 1996, Role of aldosterone in the remnant kidney model in the rat, J. Clin. Invest., 98, 1063, 10.1172/JCI118867 MacLeod, 1997, The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats, Stroke, 28, 1821, 10.1161/01.STR.28.9.1821 Nicoletti, 1995, Left ventricular fibrosis in renovascular hypertensive rats Effect of losartan and spironolactone, Hypertension, 26, 101, 10.1161/01.HYP.26.1.101 Robert, 1995, Biological determinants of aldosterone-induced cardiac fibrosis in rats, Hypertension, 26, 971, 10.1161/01.HYP.26.6.971 Brilla, 1990, Remodeling of the right and left ventricles in experimental hypertension, Circ. Res., 67, 1355, 10.1161/01.RES.67.6.1355 Brilla, 1993, Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension, Am. J. Cardiol., 71, 12A, 10.1016/0002-9149(93)90239-9 Brilla, 1994, Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone, J. Mol. Cell. Cardiol., 26, 809, 10.1006/jmcc.1994.1098 Fullerton, 1994, Aldosterone and cardiac fibrosis: in vitro studies, Cardiovasc. Res., 28, 1863, 10.1093/cvr/28.12.1863 Köhler, 1996, Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts?, J. Vasc. Res., 33, 315, 10.1159/000159159 Rocha, 2000, Aldosterone: a mediator of myocardial necrosis and renal arteriopathy, Endocrinology, 141, 3871, 10.1210/en.141.10.3871 Blasi, E.R. et al. Aldosterone/salt-induced myocardial injury: a vascular inflammatory disease. Am. J. Hypertens. (in press) Hené, 1982, Plasma aldosterone concentrations in chronic renal disease, Kidney Int., 21, 98, 10.1038/ki.1982.14 Duprez, 1993, Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension, Am. J. Cardiol. , A, 71, 17A, 10.1016/0002-9149(93)90240-D Schunkert, 1997, Associations between circulating components of the renin–angiotensin–aldosterone-system and left ventricular mass, Heart, 77, 24, 10.1136/hrt.77.1.24 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Blacher, 1997, Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension, Am. J. Hypertens., 10, 1326, 10.1016/S0895-7061(97)00301-4 Gómez-Sánchez, 1998, Primary aldosteronism and its variants, Cardiovasc. Res., 37, 8, 10.1016/S0008-6363(97)00230-7 Conn, 1964, Clinical characteristics of primary aldosteronism from an analysis of 145 cases, Am. J. Surg., 107, 159, 10.1016/0002-9610(64)90252-1 Beevers, 1976, Renal abnormalities and vascular complications in primary aldosteronism: evidence of tertiary hyperaldosteronism, Q. J. Med., 45, 401 Nishimura, 1999, Cardiovascular complications in patients with primary aldosteronism, Am. J. Kidney Dis., 33, 261, 10.1016/S0272-6386(99)70298-2 Grady, 1996, Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma, Urology, 48, 369, 10.1016/S0090-4295(96)00166-5 Halimi, 1995, Albuminuria in untreated patients with primary aldosteronism or essential hypertension, J. Hypertens., 13, 1801, 10.1097/00004872-199512010-00054 Takeda, R. et al. and the Research Committee of Disorders of Adrenal Hormones in Japan (1995) Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J. Endocrinol. Invest. 18, 370–373 Rossi, 1996, Changes in left ventricular anatomy and function in hypertension and primary aldosteronism, Hypertension, 27, 1039, 10.1161/01.HYP.27.5.1039 Litchfield, 1998, Intracranial aneurysm and hemorrhagic stroke in glucocorticoid remediable aldosteronism, Hypertension, 31, 445, 10.1161/01.HYP.31.1.445 Denolle, 1993, Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma, Am. J. Hypertens., 6, 907, 10.1093/ajh/6.11.907 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, New Engl. J. Med., 341, 709, 10.1056/NEJM199909023411001